HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M de Boer Selected Research

Type 1 Ribosome Inactivating Proteins

8/2000In vitro anti-tumour activity of anti-CD80 and anti-CD86 immunotoxins containing type 1 ribosome-inactivating proteins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M de Boer Research Topics

Disease

13Breast Neoplasms (Breast Cancer)
10/2023 - 10/2012
3Autoimmune Diseases (Autoimmune Disease)
01/2017 - 09/2001
3Chronic Granulomatous Disease
10/2009 - 01/2000
2Neoplasm Metastasis (Metastasis)
02/2016 - 04/2015
1Peri-Implantitis
01/2022
1Diverticulum
12/2020
1Immune System Diseases (Immune Disorders)
12/2017
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2017
1Drug-Related Side Effects and Adverse Reactions
01/2017
1Mental Disorders (Mental Disorder)
01/2017
1Wounds and Injuries (Trauma)
10/2016
1Dementia (Dementias)
01/2016
1Uveitis
11/2015
1Disease Progression
02/2014
1Febrile Neutropenia
10/2013
1Neoplasms (Cancer)
10/2012
1Neoplasm Micrometastasis
10/2012
1Hypertrophy
01/2007
1Hyperplasia
11/2003
1Epstein-Barr Virus Infections
11/2003
1Multiple Sclerosis
09/2001
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
09/2001
1Paratuberculosis (Johne's Disease)
03/2001
1Asthma (Bronchial Asthma)
01/2001
1Hypersensitivity (Allergy)
01/2001
1Hodgkin Disease (Hodgkin's Disease)
08/2000
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2000
1Inflammation (Inflammations)
06/2000

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
12/2017 - 03/2001
34- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
10/2009 - 01/2000
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2017 - 10/2013
2Docetaxel (Taxotere)FDA Link
10/2017 - 10/2013
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2017 - 10/2013
2Hormones (Hormone)IBA
02/2016 - 04/2015
2Oxidoreductases (Dehydrogenase)IBA
02/2014 - 01/2000
2NADPH Oxidases (NAD(P)H oxidase)IBA
10/2009 - 04/2009
2Peptides (Polypeptides)IBA
10/2009 - 04/2009
2cytochrome b558IBA
04/2009 - 01/2000
2AntigensIBA
03/2001 - 08/2000
1Protease Inhibitors (Protease Inhibitor)IBA
12/2020
1eribulinFDA Link
01/2020
1exemestane (Aromasin)FDA Link
04/2019
1EverolimusFDA Link
04/2019
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2018
1Complement C4 (Complement Component 4)IBA
12/2017
1Bevacizumab (Avastin)FDA Link
01/2017
1taxaneIBA
01/2017
1BenzodiazepinesIBA
01/2017
1SiliconesIBA
01/2017
1HLA-B27 Antigen (HLA B27 Antigen)IBA
11/2015
1IgG Receptors (Fc gamma RI)IBA
09/2015
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2013
1RNA (Ribonucleic Acid)IBA
11/2003
1LigandsIBA
09/2001
1Monoclonal AntibodiesIBA
09/2001
1lipoarabinomannan (LAM)IBA
03/2001
1Tuberculin (PPD)IBA
03/2001
1Immunoglobulin G (IgG)IBA
03/2001
1Heat-Shock Proteins (Heat-Shock Protein)IBA
03/2001
1AllergensIBA
01/2001
1Immunoglobulin E (IgE)IBA
01/2001
1anti-IgE antibodiesIBA
01/2001
1Type 1 Ribosome Inactivating ProteinsIBA
08/2000
1Immunotoxins (Immunotoxin)IBA
08/2000
1Messenger RNA (mRNA)IBA
06/2000
1CD40 Ligand (CD40L)IBA
06/2000
1CytokinesIBA
06/2000
1Interleukin-12 (IL 12)IBA
06/2000
1neutrophil cytosol factor 67KIBA
01/2000

Therapy/Procedure

7Therapeutics
10/2023 - 08/2000
4Drug Therapy (Chemotherapy)
01/2020 - 02/2016
2Adjuvant Chemotherapy
10/2023 - 10/2013
2Neoadjuvant Therapy
10/2017 - 10/2013
1Ligation
01/2022
1Radiotherapy
01/2018
1Adjuvant Radiotherapy
01/2018
1Breast Implants (Breast Implant)
01/2017
1Free Tissue Flaps
10/2016
1Palliative Care (Palliative Therapy)
02/2016
1Self-Help Devices (Assistive Technology)
01/2016
1Resistance Training
01/2007